Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank58
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-64.92M
↑ 30% vs avg
Percentile
P58
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-92.50M
Historical baseline
PeriodValueYoY Change
2025$-64.92M+50.8%
2024$-132.06M-49.3%
2023$-88.48M-1.8%
2022$-86.91M+4.4%
2021$-90.86M-78.1%
2020$-51.02M+68.4%
2019$-161.35M-21.6%
2018$-132.74M-93.7%
2017$-68.52M-42.5%
2016$-48.08M-